APA (7th ed.) Citation

Chawanpaiboon, S., Wutthigate, P., Anuwutnavin, S., & Sutchritpongsa, S. Double-blind, non-inferiority, randomized controlled trial of dexamethasone 4, 5 and 6 mg for preventing adverse neonatal and maternal outcomes in very preterm to late preterm pregnancies between 29 0 and 36 6 weeks of gestation: Study protocol. BMC.

Chicago Style (17th ed.) Citation

Chawanpaiboon, Saifon, Punnanee Wutthigate, Sanitra Anuwutnavin, and Sureelak Sutchritpongsa. Double-blind, Non-inferiority, Randomized Controlled Trial of Dexamethasone 4, 5 and 6 mg for Preventing Adverse Neonatal and Maternal Outcomes in Very Preterm to Late Preterm Pregnancies Between 29 0 and 36 6 weeks of Gestation: Study Protocol. BMC.

MLA (9th ed.) Citation

Chawanpaiboon, Saifon, et al. Double-blind, Non-inferiority, Randomized Controlled Trial of Dexamethasone 4, 5 and 6 mg for Preventing Adverse Neonatal and Maternal Outcomes in Very Preterm to Late Preterm Pregnancies Between 29 0 and 36 6 weeks of Gestation: Study Protocol. BMC.